Loading...

AMERICAN BIOGENETIC SCIENCES INC Earnings Reports 8-K Filing

MRCN

AMERICAN BIOGENETIC SCIENCES INC

()

2025 8-K

Strong Financial Results

Financial Results Update

Debt Repurchase Agreement

Board Expansion

Financial Update

Debt Conversion Update

Private Placement Deal

Product Launch Announcement

Corporate Presentation Rele...

Debt Repurchase Agreement

New Screening Tool

Market Expansion

Investor Meetings

Debt Restructuring

Financial Statements

Earnings Report

Earnings Report

Partnership Expansion

Strategic Partnership

External Links:

AMERICAN BIOGENETIC SCIENCES INC reported a significant increase in its revenue by 25% for the quarter ending September 30, 2023, compared to the previous year, driven by higher product sales.

AI Assistant

AMERICAN BIOGENETIC SCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.